US 10500284
Pharmaceutical formulation
granted A61KA61K31/573A61K31/661
Quick answer
US patent 10500284 (Pharmaceutical formulation) held by Semnur Pharmaceuticals, Inc. expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Semnur Pharmaceuticals, Inc.
- Grant date
- Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/573, A61K31/661, A61K45/06, A61K47/02